We compared the effect of proteasome inhibition on HSPA2 expression in NCI-H1299, NCI-H23 and MCF7 cancer cell lines derived from non-small cell lung cancer (NSCLC) and breast cancer, respectively. This evidence concerns the gene HSPA2 and breast cancer.